Join
Live feed
·
INSIDERFilingvia Quantisnow
Alexion Pharmaceuticals, Inc. logo

SEC Form 4: ORLOFF JOHN J was granted 60,144 units of Common Stock, increasing direct ownership by 70% to 146,511 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ALXN (Alexion Pharmaceuticals, Inc.) and more on Quantisnow.